ReportGem ReportGem EN

实时全球研报

Hyundai Motor India (HYUN.NS): June‘26 Sales: Domestic Volumes down 10% YoY; Exports Down 31% YoY Due to Temporary Disruptions

发布日期: 2026-07-01研究机构: Citi公司 / 股票: HYUN.NS报告页数: 11原文语言: English证据页码: 3

研报英文原文证据摘录

Hyundai Motor India (HYUN.NS): June‘26 Sales: Domestic Volumes down 10% YoY; Exports Down 31% YoY Due to Temporary Disruptions

Hyundai Motor India (HYUN.NS)

01 July 2026 Citi Research

Hyundai Motor India

Valuation

Our target price for Hyundai Motor India stock is Rs2,450, based on 24xSep’27E EV/EBIT. Our target multiple for HMIL is at

around a 15% discount to the target EV/EBIT multiple of 28x we use to value Maruti Suzuki, the industry leader (the Maruti

target multiple is, in turn, based on a 20% premium to Maruti’s own trailing five-year average EV/EBIT trading multiple). While

acknowledging that HMIL has a more premium product profile and a strong parentage, we think that the discount to Maruti is

justified due to: 1) Maruti’s much higher market share and greater scale of manufacturing, and 2) proven track record of Maruti’s

parent company (Suzuki) in executing India-focused strategies.

Risks

Generally, recently listed companies are assigned a High Risk rating by our Quant risk model owing to their limited trading

history. In that context, HMIL is rated High Risk as per our Quant risk model. However, HMIL has a healthy balance sheet and

cash flow generation, as well as strong parentage, and in that context we do not apply a High Risk rating.

Key downside risks that could impede the shares from reaching our target price include: 1) intense competition from domestic

and foreign automobile manufacturers resulting in a risk of decline in market share; 2) risks due to related-party transactions

and reliance on group affiliates including royalty to HMC (parent) and sourcing of parts and revenue from related parties. HMIL

is also dependent on the group to provide parts to dealers and distributors for after-sale services; 3) changing customer

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器